Assembly Biosciences, Inc. Alternatives & Competitors
12 companies similar to Assembly Biosciences, Inc. — Passionate about making a profound impact on patients’ lives
Companies similar to Assembly Biosciences, Inc.
Replicor Inc.
292 million people have chronic hepatitis B. We're developing the cure.
Montreal, Canada
ANA Therapeutics
We’re investigating niclosamide as a treatment for COVID-19.
San Mateo, United States
Anadys Pharmaceuticals
Pioneering the future of hepatitis C treatment with innovative antiviral therapies
Panacos Pharmaceuticals
Innovative solutions in the fight against HIV and other viral diseases using advanced smal...
Track all Assembly Biosciences, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
ViroCarb Inc.
Antiviral company with a paradigm shift drug platform that provides broad-spectrum protect...
Toronto, Canada
Altay Therapeutics
Unlocking Transcription Factors to Address Unmet Medical Need
San Francisco, United Sta...
Aligos Therapeutics
Improving patient outcomes through best-in-class therapies for liver and viral diseases
South San Francisco, Unit...
Cidara Therapeutics
Leading the Science of Protection
San Diego, United States
1910 Genetics
Advancing small and large molecule drug discovery with a multimodal AI platform powered by...
Boston, United States
Remix Therapeutics
Reprogramming RNA Processing, Designing Therapeutic Solutions
United States
Bluejay Therapeutics
Developing innovative cures for infectious diseases with the first target indication of ch...
United States
About Assembly Biosciences, Inc.
Assembly Biosciences, Inc. is a biotechnology company founded in 2014 and based in South San Francisco, United States. Their focus is on developing innovative small molecule antiviral therapeutics aimed at altering the course of significant viral diseases, addressing conditions like herpesvirus, hepatitis B, and hepati...
Development of novel therapies, Clinical studies and trials, Innovative drug pipeline
Patients with viral diseases, Patients with liver diseases, Healthcare providers, Biopharmaceutical investors
Antiviral Therapeutics, Small Molecule Drugs, Herpesvirus Treatment, Hepatitis B Treatment, Hepatitis D Treatment, Virologic Drug Development, Infectious Disease Research, Therapeutic Innovation, Chronic Viral Infection Management, Pharmaceutical Development, Healthcare Impact, South San Francisco Biotech
B2B, B2B2C
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Assembly Biosciences, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Assembly Biosciences, Inc. on 15 Jun 2026. The 12 companies listed here were last checked between 25 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
